NCT05943743

Brief Summary

The COVID-19 Pandemic is the characterizing worldwide wellbeing emergency within recent memory. Since its development in Asia before the end of last year, the infection has spread to each mainland with the exception of Antarctica. Countries are dashing to moderate the spread of the illness by testing and treating patients, completing contact following, restricting travel, isolating residents, and dropping huge social occasions like games, shows, and educational institutes. As almost every institution was closed for the safety of human kind. All educational institutes were also closed for any kind of education. Also, In Pakistan all educational institutes were closed since march 2020. It was impossible to keep educational activities closed for long. In order to keep educational activities in working e-learning was introduced through out the world. As many other countries Pakistan also started e-learning for all students.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 20, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 16, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

January 7, 2025

Status Verified

January 1, 2025

Enrollment Period

2.3 years

First QC Date

March 16, 2023

Last Update Submit

January 6, 2025

Conditions

Keywords

Covid-19obstaclesScreen Time

Outcome Measures

Primary Outcomes (1)

  • Difference of students educational level will assessed using Likert scale

    During lockdown due to covid-19 medical students studies effected drastically. Academic level will be measured through likert scale in which 1 means good, 2 means average and 3 means below average. Academic level will be compared on the basis of students reply before and during covid academic result.

    30 days

Secondary Outcomes (1)

  • Majority of students are facing internet and accessibility problems during online classes

    30 days

Other Outcomes (1)

  • Level of interest among students were very low due to online classes

    30 days

Interventions

* Self-administrated Questionnaire will be used for online survey. A pilot study was conducted on 30 sample size to check the reliability of questionnaire via statistical test. * A Five-point Likert scale (strongly disagree, disagree somewhat, Neutral, agree somewhat, strongly agree)

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Undergraduate students of both private and government sector of medical institutes.

You may qualify if:

  • All undergraduate medical students of Pakistan.

You may not qualify if:

  • Postgraduate Medical students Teaching Faculty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BUMDC

Karachi, Sindh, 75500, Pakistan

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Rabia Khan, Msc(PT)

    Bahria University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rabia Khan, Msc(PT)

CONTACT

Muhammad Usman, PPDPT

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 16, 2023

First Posted

July 13, 2023

Study Start

December 20, 2022

Primary Completion

March 30, 2025

Study Completion

December 15, 2025

Last Updated

January 7, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Data collection procedure, results and limitation and strengths will be shared through publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
By the end of year 2023
Access Criteria
Publications

Locations